<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1679-4974</journal-id>
<journal-title><![CDATA[Epidemiologia e Serviços de Saúde]]></journal-title>
<abbrev-journal-title><![CDATA[Epidemiol. Serv. Saúde]]></abbrev-journal-title>
<issn>1679-4974</issn>
<publisher>
<publisher-name><![CDATA[Secretaria de Vigilância em Saúde e Ambiente - Ministério da Saúde do Brasil]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1679-49742017000300513</article-id>
<article-id pub-id-type="doi">10.5123/s1679-49742017000300009</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Avaliação da rede de diagnóstico laboratorial na implantação do Programa de Prevenção e Controle das Hepatites Virais no estado de São Paulo, 1997-2012]]></article-title>
<article-title xml:lang="en"><![CDATA[Assessment of laboratory diagnostic network in the implementation of the Program for Viral Hepatitis Prevention and Control in São Paulo State, Brazil, 1997-2012]]></article-title>
<article-title xml:lang="es"><![CDATA[Evaluación de la red de diagnóstico de laboratorio en la implementación del Programa de Prevención y Control de las Hepatitis Virales en el estado de São Paulo, Brasil, 1997 - 2012]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marques]]></surname>
<given-names><![CDATA[Cristiano Corrêa de Azevedo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carvalheiro]]></surname>
<given-names><![CDATA[José da Rocha]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Secretaria de Estado da Saúde de São Paulo Instituto Butantan ]]></institution>
<addr-line><![CDATA[São Paulo SP]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Secretaria de Estado da Saúde de São Paulo Instituto de Saúde ]]></institution>
<addr-line><![CDATA[São Paulo SP]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2017</year>
</pub-date>
<volume>26</volume>
<numero>3</numero>
<fpage>513</fpage>
<lpage>524</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_arttext&amp;pid=S1679-49742017000300513&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_abstract&amp;pid=S1679-49742017000300513&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_pdf&amp;pid=S1679-49742017000300513&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  OBJETIVO:  avaliar o desempenho da rede de diagnóstico no processo de implantação do Programa de Prevenção e Controle das Hepatites Virais (PEHV) no estado de São Paulo, Brasil, no período de 1997 a 2012.  MÉTODOS:  estudo avaliativo baseado em pesquisa documental e entrevista estruturada, associadas a uma análise de séries históricas de indicadores desenvolvidos para avaliar o processo de implantação do PEHV, utilizando dados do Departamento de Informática do Sistema Único de Saúde (Datasus).  RESULTADOS:  entre 1997 a 2012, as redes de diagnóstico sorológico, biópsia e biologia molecular apresentaram aumento dos coeficientes de cobertura de 7,4, 7,3 e 62,0 vezes, respectivamente, com aumento das notificações de portadores e do acesso ao tratamento.  CONCLUSÃO:  apesar da efetiva implantação da rede diagnóstica no PEHV, verifica-se a necessidade de revisão da estratégia de busca de novos portadores e acesso à biópsia de fígado, ainda insuficiente para a demanda do programa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE:  to assess the performance of the diagnostic network in the implementation process of the Program for Viral Hepatitis Prevention and Control in São Paulo State, Brazil, from 1997 to 2012.  METHODS:  evaluation study based on documentary research and structured interviews, combined with a historical series analysis of indicators developed to assess the implementation process of the program, using data from the Department of the Brazilian National Health System.  RESULTS:  from 1997 to 2012, the serology, biopsy and molecular biology diagnostic networks showed an increase in the coefficients of coverage of 7.4, 7.3, and 62.0 times, respectively, with an increase in cases detection and treatment access.  CONCLUSION:  despite the effective implementation of the diagnostic network, there is a need to review the search strategy for new cases, and access to liver biopsy, still insufficient to the program demand.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO:  evaluar el desempeño de la red de diagnóstico en el proceso de implementación del Programa de Prevención y Control de la Hepatitis Viral en São Paulo, Brasil, de 1997 a 2012.  MÉTODOS:  estudio de evaluación utilizando métodos mixtos - investigación documental y entrevistas estructuradas -, con análisis de series históricas de indicadores desarrollados para evaluar la implementación del programa, mediante el Departamento de Informática del SUS (Datasus).  RESULTADOS:  las redes de diagnóstico de serología, biopsia y biología molecular tuvieron, entre 1997 a 2012, un aumento de los índices de cobertura en el orden de 7,4; 7,3 y 62,0 veces, respectivamente, con un crecimiento en los informes de los pacientes y acceso al tratamiento.  CONCLUSIÓN:  a pesar de la implementación efectiva de la red de diagnóstico para el programa, hay que revisar la estrategia de búsqueda de portadores, y acceso a biopsia de hígado, aún insuficiente para la demanda del programa.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Hepatite Viral Humana]]></kwd>
<kwd lng="pt"><![CDATA[Planos e Programas de Saúde]]></kwd>
<kwd lng="pt"><![CDATA[Técnicas e Procedimentos Diagnósticos]]></kwd>
<kwd lng="pt"><![CDATA[Estudos de Avaliação]]></kwd>
<kwd lng="en"><![CDATA[Hepatitis Viral Human]]></kwd>
<kwd lng="en"><![CDATA[Health Programs and Plans]]></kwd>
<kwd lng="en"><![CDATA[Diagnostic Techniques and Procedures]]></kwd>
<kwd lng="en"><![CDATA[Evaluation Studies]]></kwd>
<kwd lng="es"><![CDATA[Hepatitis Viral Humana]]></kwd>
<kwd lng="es"><![CDATA[Planes y Programas de Salud]]></kwd>
<kwd lng="es"><![CDATA[Técnicas y Procedimientos Diagnósticos]]></kwd>
<kwd lng="es"><![CDATA[Estudios de Evaluación]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The global burden of hepatitis C]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lavanchy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Liver Int]]></source>
<year>2009</year>
<volume>29</volume>
<numero>1^sSuppl</numero>
<issue>1^sSuppl</issue>
<supplement>Suppl</supplement>
<page-range>74-81</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Hepatitis B]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Hepatitis C]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Top ten biotechnologies for improving health in developing countries]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Daar]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Thorsteinsdóttir]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Nast]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Singer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Genet]]></source>
<year>2002</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>229-32</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis interventional therapy group]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[McHutchison]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Schiff]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Shiffman]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Rustgi]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
</person-group>
<source><![CDATA[New Engl J Med]]></source>
<year>1998</year>
<volume>339</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>1485-92</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poynard]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Marcellin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Niederau]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Minuk]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Ideo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>1998</year>
<volume>352</volume>
<numero>9138</numero>
<issue>9138</issue>
<page-range>1426-32</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Resolução SS nº 77, de 3 de julho de 2001. Institui o Comitê Assessor Permanente de Hepatites Virais da Secretaria de Estado da Saúde de São Paulo]]></article-title>
<collab>Secretaria de Estado da Saúde (São Paulo)</collab>
<source><![CDATA[]]></source>
<year>2001</year>
<page-range>23</page-range><publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial do Estado de São Paulo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Portaria nº 263, de 5 de fevereiro de 2002]]></article-title>
<collab>Brasil. Ministério da Saúde</collab>
<source><![CDATA[]]></source>
<year>2002</year>
<page-range>49</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Creswell]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[VLP]]></given-names>
</name>
</person-group>
<source><![CDATA[Pesquisa de métodos mistos]]></source>
<year>2013</year>
<edition>2 ed</edition>
<publisher-loc><![CDATA[Porto Alegre ]]></publisher-loc>
<publisher-name><![CDATA[Penso]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<collab>Secretaria de Estado de Saúde (São Paulo)</collab>
<source><![CDATA[Manual de vigilância epidemiológica de Hepatites Virais: normas e instruções]]></source>
<year>2000</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Secretaria de Estado de Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<collab>Secretaria de Estado de Saúde (São Paulo)</collab>
<source><![CDATA[Guia de orientações técnicas Hepatites B e C]]></source>
<year>2002</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Secretaria de Estado de Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<collab>Ministério da Saúde. Secretaria de Políticas de Saúde. Programa Nacional de Hepatites Virais</collab>
<source><![CDATA[Hepatites Virais: o Brasil está atento]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Resolução SS nº 137, de 5 de agosto de 1998. Aprova a revisão do protocolo técnico do programa de dispensação de medicamentos de alto custo]]></article-title>
<collab>São Paulo. Secretaria de Estado da Saúde de São Paulo</collab>
<source><![CDATA[]]></source>
<year>1998</year>
<page-range>11</page-range><publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial do Estado de São Paulo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Portaria nº 639, de 21 de junho de 2000]]></article-title>
<collab>Brasil. Ministério da Saúde</collab>
<source><![CDATA[]]></source>
<year>2000</year>
<page-range>33</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donabedian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Explorations in quality assessment and monitoring]]></source>
<year>1980</year>
<volume>Vol. I</volume>
<page-range>163 p</page-range><publisher-loc><![CDATA[Ann Harbor ]]></publisher-loc>
<publisher-name><![CDATA[Health Administration Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<collab>Grupo Esperança</collab>
<source><![CDATA[Informações e objetivos]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Santos ]]></publisher-loc>
<publisher-name><![CDATA[Grupo Esperança]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<collab>Universidade Federal de São Paulo</collab>
<source><![CDATA[Histórico]]></source>
<year>2016</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Hospital São Paulo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Portaria nº 1461, de 22 de dezembro de 1999. Dispõe sobre as doenças que constituem objeto de notificação compulsória em todo o território nacional, como também todo e qualquer surto ou epidemia, juntos às Secretarias Municipais e Estaduais de Saúde e à Fundação Nacional de Saúde - FUNASA]]></article-title>
<collab>Brasil. Ministério da Saúde</collab>
<source><![CDATA[]]></source>
<year>1999</year>
<page-range>34</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Portaria GM-MS nº 1230, de 14 de outubro de 1999. Implanta no SIA/SUS a tabela de codificação de procedimentos de 8 dígitos, constante no anexo desta portaria]]></article-title>
<collab>Brasil. Ministério da Saúde</collab>
<source><![CDATA[]]></source>
<year>1999</year>
<page-range>12</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Portaria GM/MS no 1320, de 23 de julho de 2002. Inclui na tabela de procedimentos SIA/SUS o procedimento relacionado em anexo]]></article-title>
<collab>Brasil. Ministério da Saúde</collab>
<source><![CDATA[]]></source>
<year>2002</year>
<page-range>81</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnóstico molecular de Hepatite C dos pacientes atendidos pelo Instituto Adolfo Lutz Central, entre março de 2012 e março de 2013]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Compri]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Oba]]></surname>
<given-names><![CDATA[IT]]></given-names>
</name>
<name>
<surname><![CDATA[Constantino]]></surname>
<given-names><![CDATA[CRA]]></given-names>
</name>
<name>
<surname><![CDATA[Moreira]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
</person-group>
<source><![CDATA[BEPA]]></source>
<year>2015</year>
<volume>12</volume>
<numero>139</numero>
<issue>139</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Programa de Hepatites Virais no estado de São Paulo, 2000-2015]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coelho]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Farias]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Camis]]></surname>
<given-names><![CDATA[MCRS]]></given-names>
</name>
</person-group>
<source><![CDATA[BEPA]]></source>
<year>2015</year>
<volume>12</volume>
<numero>141</numero>
<issue>141</issue>
<page-range>25-34</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="book">
<collab>Grupo Esperança</collab>
<source><![CDATA[Encontro]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Santos ]]></publisher-loc>
<publisher-name><![CDATA[Grupo Esperança]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Portaria nº 968, de 11 de dezembro de 2002]]></article-title>
<collab>Brasil. Ministério da Saúde</collab>
<source><![CDATA[]]></source>
<year>2002</year>
<page-range>248</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Ato 55/2009]]></article-title>
<collab>São Paulo. Assembleia Legislativa</collab>
<source><![CDATA[]]></source>
<year>2009</year>
<volume>119</volume>
<numero>97</numero>
<issue>97</issue>
<page-range>14</page-range><publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial do Estado de São Paulo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogel]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
</person-group>
<source><![CDATA[As frentes parlamentares e a cultura política em defesa dos direitos humanos]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Biblioteca Digital da Câmara dos Deputados]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Lei nº 11.255, de 27 de dezembro de 2005. Define as diretrizes da Política de Prevenção e Atendimento Integral à Saúde da Pessoa Portadora de Hepatite, em todas as suas formas, no âmbito do Sistema Únicos de Saúde - SUS, e dá outras providências]]></article-title>
<collab>Brasil. Presidência da República</collab>
<source><![CDATA[]]></source>
<year>2005</year>
<page-range>16</page-range><publisher-loc><![CDATA[Brasília (DF) ]]></publisher-loc>
<publisher-name><![CDATA[Diário Oficial da República Federativa do Brasil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Avaliação do processo de dispensação de medicamentos aos portadores de hepatite C crônica em farmácias de componentes de especializados da Secretaria de Estado da Saúde de São Paulo, em 2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Venâncio]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Bersusa]]></surname>
<given-names><![CDATA[AAS]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
<name>
<surname><![CDATA[Figueiredo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Awakamatsu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[VAF]]></given-names>
</name>
</person-group>
<source><![CDATA[Epidemiol Serv Saude]]></source>
<year>2014</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>701-10</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="book">
<collab>Departamento de IST, Aids e Hepatites Virais</collab>
<source><![CDATA[Estudo de prevalência de base populacional das infecções pelos vírus das hepatites A, B e C nas capitais do Brasil]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
